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Abstract
Introduction: The range shifter (RS) is used to treat shallow tumors for a proton pencil beam scanning system (PBS).
Adding RS certainly complicates the commissioning of the treatment planning system (TPS) because the spot sizes are
significantly enlarged with RS. In this work, we present an efficient method to configure a commercial TPS for a PBS
system with a fixed RS.
Methods: By combining a spiral delivery with customized control points, we were able to significantly improve
measurement efficiency and obtain 250 field size factors (FSF) within three hours. The measured FSFs were used
to characterize the proton fluence and fit the parameters for the double-Gaussian fluence model used in the TPS.
Extensive validation was performed using FSFs measured in air and in water, absolute doses of spread-out Bragg
peak (SOBP) fields, and the dose measurements carried out for patient-specific quality assurance (QA).
Results: The measured in-air FSFs agreed with the model’s prediction within 3% for all 250 FSFs, and within 2 for
94% of the FSFs. The agreement between model’s prediction and measurement was within 2% for the in-air and
in-water FSFs and the absolute doses for SOBP beams. The patient-specific QA of 113 fields showed an excellent
gamma passing rates (96.95 ± 2.51%) for the absolute dose comparisons with gamma criteria of 2 mm and 2%.
Conclusion: The excellent agreement between the model’s prediction and measurements proved the efficiency
and accuracy of the proposed method of using FSFs to characterize the proton fluence and configure the TPS for
a PBS system with fixed RS.
Keywords: Proton pencil beam scanning, Range shifter, Field size factor, Double Gaussians fluence, TPS
commissioning
Introduction
The pencil beam scanning (PBS) technique has gained
more popularity in proton centers [1] because PBS has
reduced neutron dose, no need for apertures and com-
pensators, and intrinsically enables intensity modulated
proton therapy (IMPT) [2]. Due to technical challenges,
current clinical PBS systems cannot provide protons
with energies below 70 MeV [3]. This limits the ability
to treat shallow tumors (<4 cm) unless a range shifter
(RS) is added at the end of the nozzle.
The PROBEAT-V (Hitachi Ltd., Tokyo, Japan) proton
system at our institution produces a nominal minimum
energy beam of 71.3 MeV, corresponding to a range of
4 cm in water. A fixed RS with a water equivalent thick-
ness (WET) of 4.5 cm can be attached at the end of the
non-movable nozzle, 30 cm from isocenter. The dose al-
gorithm used in our institution is the proton convolution
superposition (PCS) dose algorithm in the Eclipse™ treat-
ment planning system (TPS) (Varian Medical Systems,
Palo Alto, CA). The PCS algorithm is a fluence-based dose
model that calculates dose by convolving the proton flu-
ence with a dose kernel hardcoded inside the TPS [4, 5].
The spot sizes of proton beamlets increase when the
RS is used, and the increases are more pronounced for
low proton energies [6]. This is due to the scattering of
protons from the RS and the large air gap between the
RS and isocenter. Additionally, the RS creates low-signal
tails in the beam profile due to large-angle multiple* Correspondence: Shen.Jiajian@Mayo.edu
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Coulomb scattering and nuclear interactions. These low-
signal tails can extend laterally more than 10 cm from
the spot center [7, 8]. Clinically these low dose tails
manifest themselves in an increase of output with field
sizes [9], a phenomenon known as the field size effect.
To address this clinically-relevant effect, the Eclipse PCS
algorithm utilizes two Gaussian distributions to model
the proton fluence: one for the primary fluence and the
second for the tails [10]. The modeling process for a RS
in a TPS is further complicated by spot size enlargement
and the associated low-dose tails.
Methods for configuring the double-Gaussian fluence
model in the Eclipse TPS have already been extensively
investigated for a PBS system without a RS (vacuum ma-
chine) [10]. However, to the best of our knowledge no
one has reported a method for configuring a TPS model
for a PBS system with a RS. Since the primary spot sizes
and tails caused by the RS are intrinsically quite different
from those of the vacuum machine, the configuration of
the model is different as well.
In this work, we propose an efficient method of using
field size factor (FSF) to characterize the in-air proton flu-
ence of a PBS system with a fixed RS, the results of which
are then used to configure a double-Gaussian model in the
Eclipse TPS. Throughout the paper, all beam energies refer
to the nominal energies at the entrance of the nozzle.
Methods and Materials
Double-Gaussian model for proton fluence
The Eclipse PCS algorithm (Version 13.7.15) calculates
dose by convolving the proton fluence with the proton
dose kernel. The dose at a given point (x, y, z) may
therefore be written as:
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kernel, d is the depth in medium, and z is the distance
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double-Gaussian fluence model, the distribution of pro-
tons is described as:
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where ΦjEk zð Þ is the maximum fluence of the spot j,
w2(Ek) is the weight of the second Gaussian function,
and σ1(Ek, z) and σ2(Ek, z) are the standard deviations of
the first and second Gaussian, respectively. Properly
configuring the model is therefore a matter of finding
the optimal values of σ1(Ek, z), σ2(Ek, z) and w2(Ek).
Field size factor measurements
Single-energy spot arrays with a uniform spot spacing of
5 mm and a 20 cm square field size were generated for ten
proton energies, ranging from 80.3 MeV to 175.9 MeV.
The spot delivery pattern was designed in such a way that
the proton beamlets were delivered in a spiral pattern, be-
ginning at the center and proceeding outward. Five control
points were also added in key places to create brief pauses
in the beam delivery. The purpose of control points is usu-
ally to pause the delivery while the system switches from
one proton energy to the next, an automatic process in
out PTB system which takes approximately two seconds.
In this case, however, they were used to provide time to
manually pause the beam and record the charge collected
by the ionization chamber before resuming delivery. The
five control points were chosen so that the beam was
paused after delivering field sizes of 2, 4, 6, 8, and 10 cm,
as shown in Fig. 1. This allowed charge readings to be re-
corded for six field sizes (including the full 20 cm field) in
around three minutes using a single beam delivery.
Reloading the spot pattern files and waiting for the proton
system’s various interlocks to clear takes time, so pausing
one beam five times represents a significant improvement
in efficiency over running six separate beams for six
different field sizes.
Fig. 1 Spiral delivery pattern with control points for efficient FSF
measurements. The red triangles show the control points used to
pause the beam delivery and record the charge. Using the spiral
pattern and the control points, a set of FSFs can be obtained by
delivering just one beam with the maximum field size (i.e., 20 cm
× 20 cm)
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In-air charge measurements were made at five posi-
tions along the beam direction (in the isocenter plane,
±10 cm and ±20 cm from isocenter) for ten proton ener-
gies ranging from 80.3 MeV to 175.9 MeV using six field
sizes (2, 4, 6, 8, 10, and 20 cm). The measurements were
made with a 34045 Advanced Markus ion chamber
(PTW, Freiburg, Germany), which has an effective vol-
ume of 0.02 cm3, radius 2.5 mm and a 1.06 mm WET
entrance window. To keep the chamber in place, it was
inserted into a cutout within a 30 cm × 30 cm × 3 cm
acrylic plate machined to hold the chamber. The cham-
ber surface and the effective measurement point (1 mm
below the surface) were aligned with the laser, and the
couch was moved vertically to bring the chamber to the
five measurement positions. At each new couch position,
beam with the smallest field size (2 cm) was delivered
five times at the center and at offsets by ±1 mm in the x
and y directions from the center, which ensures that the
chamber was properly centered before beginning the
FSF measurements. The smallest field size (2 cm) was
delivered five times and charges were collected with
beam offsets from the current center by ±1 mm in the x
and y directions, respectively. The reproducibility of the
FSF measurements was checked by repeating them mul-
tiple times on multiple days.
The FSFs were obtained by normalizing the charges
recorded at various field sizes to that of the 10 cm field.
A total of 250 FSFs were measured and used to configure
the proton fluence model (throughout this paper, the FSF
for the 10 cm field was ignored, as it was 1.0 by defin-
ition). The FSFs for all five positions for 121 MeV protons
are shown in Fig. 2, along with those for 80.3 MeV and
175.6 MeV protons at the isocenter position.
Characterizing the parameters for proton fluence
The proton fluence distribution for a single spot was
given previously in Eq. (2). The FSF for a given field size
was derived by integrating the fluence distributions from
all spots inside that field. The proton fluence (PF) at the
center of the field for a given field size (FS) and spot
spacing (SS) may be described as:
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0
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0
y ¼ SS
 SSDþdVSADy : VSADx and VSADy are the virtual SAD in the x
and y directions, respectively. SSx
' and SSy
' are the pro-
jected spot spacing in the non-isocentric plane in the x
and y directions, respectively. After the proton fluence
was calculated for each square field, the FS were obtained
by normalizing to the field size of 10 cm: FSF ¼ PF FSð ÞPF FS¼10ð Þ.
A large set of potential Gaussian fit parameters (σ1(Ek, z),
σ2(Ek, z), and w2(Ek)) were used to calculate FSFs for each
energy at all five positions. The many calculated FSFs
were then compared with the measured FSFs, and the
optimal fit parameters were chosen to be those that led
to the minimum differences between the measured and
calculated FSFs.
With RS our proton beam therapy delivery system has
a total of 68 energy layers between 80.3 MeV and
175.6 MeV. The optimal Gaussian fit parameters were
chosen based on the ten energies that we measured, and
the proton fluence parameters for the 58 remaining ener-
gies were interpolated based on these optimal fit parame-
ters. All these fluence parameters were then put into the
Eclipse TPS as part of the beam configuration process.
The sensitivity of the calculated FSFs to the various fit
parameters was investigated and is demonstrated in
Fig. 3. The ‘+’ symbol in the figure shows the initial
Fig. 2 Measured FSFs at five positons (isocenter, ±10 cm and ±20 cm)
for the proton energy of 121 MeV, and at the isocenter plane for the
proton energies of 80.3 Mev and 175.6 MeV
Fig. 3 Sensitivity of the FSF to the proton spot fluence fit parameters
for an energy of 130.9 MeV at field sizes of 2 cm (a) and 20 cm (b)
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calculated FSFs based on a typical set of fit parameters
(σ1, σ2, and w2) for nominal energy E = 130.9 MeV. Each
fit parameter was then adjusted separately and new FSFs
were calculated. The red, green and blue circles in Fig. 3
show the new FSFs found by changing the fit parameters
σ1, σ2, and w2 by ±10, ±20, and ±20%, respectively. The
greater the change in the calculated FSF, the more sensi-
tive the FSF is to that particular fit parameter. Figure 3a,
for example, shows that the FSFs for FS = 2 cm are very
sensitive to the primary Gaussian (σ1). A 10% primary
Gaussian change causes >5% change in the FSFs for this
smallest field size. However, the FSFs for this same FS =
2 cm are not sensitive to the secondary Gaussian at all:
there was virtually no change in the calculated FSF when
σ2 was changed by ±20%. Conversely, Fig. 3b shows that
the FSFs for FS = 20 cm are not sensitive to the primary
Gaussian but rather to the secondary Gaussian. The
FSFs for both FS = 2 cm and 20 cm are mildly affected
by the variation in the parameter w2. The data in Fig. 3
shows that with a set of FSFs from 2 cm to 20 cm, the
double-Gaussian fluence parameters for a RS may be
fitted with high accuracy because of these high sensitiv-
ities to the appropriate parameters in the respective
field size ranges.
Validation of the model
As was discussed previously, we measured the FSFs for
ten energies to find the proton fluence parameters and
used the results to interpolate the parameters for the
remaining 58 energies. To verify that these interpolations
were appropriate, the in-air FSFs were measured at the iso-
center position for a different set of ten energies. A total of
50 FSFs were obtained to validate the interpolations.
Since all patient treatments involve the beams passing
through a finite depth of tissue, the FSFs in water are
clinically important. We measured 55 FSFs with various
energies and depths in water and compared the results
with the corresponding values obtained from the
Eclipse TPS. This validated the model for single-energy
FSFs in water.
FSFs are relative quantities. The absolute doses in the
Eclipse TPS are from the integrated depth dose (IDD).
In our commissioning process IDDs were generated by
Monte Carlo simulation and normalized to the dose
measured at a depth of 1 cm with a Bragg peak chamber.
Various beams with different range values, spread-out
Bragg peak (SOBP) widths, and field sizes were gener-
ated in the Eclipse TPS. These beams were delivered to a
phantom using our proton beam delivery system the
measured doses were compared with those from the
Eclipse TPS. A small adjustment (up to 2%) to the IDD
dose normalization was applied in order to achieve 2%
dose agreement between the measured dose and the
dose calculated by Eclipse TPS.
Dose planes for patient-specific QA were measured with
the DigiPhant device (IBA Dosimetry, Schwarzenbruck,
Germany) at multiple depths [11]. Measurements were
also made with Gafchromic film with the one-dose proto-
col (Ashland, Bridgewater, NJ, USA) in order to take ad-
vantage of the high spatial resolution afforded by film
measurements [12].
Results
Field size factors from best fit parameters
Figure 4 shows the difference between measured FSFs and
those calculated with the best fit parameters. A total of 250
data comparisons are presented in two ways: the left panel
shows the differences grouped by various field sizes; while
the right panel shows the differences grouped by the dis-
tances from isocenter. Each box plot corresponds to 50
data comparisons, and the minimum, first quartile, median,
third quartile, maximum, and outliers are displayed in each
box plot. Figure 4 shows that all calculated FSFs were
within 3% from the measured FSFs, with most of them
within 2%. Most of the FSFs with deviations greater than
2% correspond to the largest field size of 20 cm and those
closest to the nozzle (i.e., 20 cm proximal to isocenter).
Model validation results
The results from the validation measurements discussed
in section 2.4 are shown in Fig. 5. The first box plot
shows the differences between the measured results and
those calculated in the Eclipse TPS with the interpolated
parameters for the 50 in-air single-energy FSFs. The sec-
ond box plot shows the same for the 55 in-water single-
energy FSFs. The third box plot shows the absolute dose
difference between the Eclipse TPS and the measure-
ments for the SOBP beams. All variations in the three
box plots are within 2%, indicating that the model using
parameters optimized based on FSFs is valid.
Figure 6 shows the patient-specific QA result for an
IMPT plan for a head-and-neck cancer patient. The mea-
surements were made using Gafchromic film, and the
gamma passing rate for the absolute dose comparisons
with criteria of 2%, 2 mm, 10% threshold was 99.47%. The
same kind of measurement (not shown here) was also done
using a MatriXX PT, which gave a gamma passing rate of
99.36%. Overall, we have done patient-specific QA for 113
fields with the same criteria as mentioned above, and the
gamma passing rates have been excellent (96.95% ±2.51%,
ranging from 89.55 to 99.90%). These high gamma passing
rates for patient QA solidifies the fact that the model with
parameters fit by the FSFs is very good.
Discussion
In this paper, we presented an efficient method for using
FSFs to characterize the in-air proton fluence of single
proton spots in the presence of a fixed RS. The derived
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proton fluence parameters for a double Gaussian model
were used to configure the PCS algorithm in the Eclipse
TPS. The method and the model were extensively vali-
dated by both in-air and in-water measurements for
single-energy beams, SOBP beams, and patient-specific
QA. All the validations show that the method is robust
and the model is excellent.
The FSF measurements presented in this paper uti-
lized a spiral delivery pattern and added control points.
As shown in Fig. 1, this method is very efficient because
several FSFs can be obtained by delivering a single beam.
It took approximately three hours to measure 250 FSFs
for ten energies at five different phantom positions relative
to the proton nozzle. We then interpolated the optimal fit
parameters for the proton fluence to the remaining ener-
gies. With these efficient FSF measurements, the entire
proton fluence model was configured using direct mea-
surements, without using any Monte Carlo simulation
data. Instead, the FSF measurements provide useful infor-
mation on in-air proton fluence that can improve the
Monte Carlo simulation.
While the proton fluence for a single proton spot can
be measured by high resolution detectors such as film,
diodes, pinpoint chambers, and scintillators [7, 13], these
measurements are usually time consuming, sensitive to
setup errors, or need post-processing. It is especially
challenging to measure the low-dose tails directly be-
cause a large number of monitor units are needed to in-
crease the low-dose signals to the measurable level.
Conversely, the FSFs were measured using homogeneous
square fields, which are less affected by setup errors.
The reproducibility tests for the repeated measurements
on the same day and on different days showed a max-
imum deviation of < 0.5% and a standard deviation of
0.2%. Fig. 3a shows that the FSFs are very sensitive to
the σ1 of the primary Gaussian for the 2 cm field size.
For spot sizes less than 5 mm, it is quite possible that
any direct spot profile measurements would bring sub-
mm measurement uncertainties. However, Fig. 3a shows
that even a 0.5 mm deviation may cause an error in FSFs
greater than 5%, which is certainly not negligible. There-
fore, the FSF measurements for the RS are more accur-
ate and robust in characterizing the proton fluence.
Fig. 5 Validation of the model by the measurements. The first box
plot has 50 in-air FSF comparisons for the ten new energies in which
the calculated FSFs were obtained from the interpolated fluence
parameters. The second box has 55 FSF comparisons for different
energies and depths in water. The third box has 66 absolute dose
comparisons between the calculations from the Eclipse TPS and the
measurements for various ranges, SOBP widths, and field sizes
Fig. 4 Differences in the FSF between the measurement and the calculation using optimal fit parameters. A total of 250 FSF comparisons are
presented in two ways: grouped by the field size and by the distance from the isocenter. Each box plot represents a sample size of 50 FSF
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Fig. 6 Patient-specific QA for an IMPT plan. The gamma passing rate for an absolute dose comparison was 99.47% for criteria of 2 mm, 2 and
10% threshold
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Since IMPT has the capability to provide high dose
conformity, it has increasingly been used in treating
complex tumors, such as head-and-neck cancers [14].
For a highly-modulated plan, there are no homogenous
dose distributions for any of the constituting fields, and
the heavy modulation of each field generates high dose
gradients inside the target. In cases such as this, it is es-
pecially critical to have an accurate model of both the
primary proton fluence and that of the extended tails. If
only a single-Gaussian model is used, the output can be
off by more than 10%, as reported by Zhu et al. 2013
[10]. For the modelling of the extended tails, it is re-
ported that a proper characterization of the tail compo-
nent of the beam, below a factor of 10−4 of the central
axis dose, is necessary to avoid dose inaccuracies [7].
Therefore, achieving an accurate dose calculation for an
IMPT plan relies on the accurate modelling of every
spot including 1st and 2nd Gaussian as well as their rela-
tive weights.
Figure 4 shows that the model with parameters derived
from measured FSFs can predict FSFs to within 2% for
most cases and to within 3% for all cases. It is worth
noting that the proton spot profiles are not intrinsically
double-Gaussian in shape, particularly for the laterally-
extending low-dose tails. It was reported that adding an
additional Cauchy-Lorentz function may fit measured
profiles better [15]. Therefore, it is not unexpected that
the double-Gaussian model does not fit every situation
perfectly (e.g., within 2%). Nevertheless, as shown in
Fig. 4, the few cases of up to 3% deviation were found
for 20 cm field size and at a distance of 20 cm away
from isocenter, both of which are clinically rare situa-
tions. Figure 5 shows that the accuracy of the fluence
model was better than 2% for the FSFs measured in air
and in water and for the absolute doses of the SOBP
beams. These high-accuracy validations guarantee a
precise model for the prediction of patient dose, as
demonstrated by the high gamma passing rate for
patient-specific QA shown in Fig. 6.
In this paper, we have limited the highest proton en-
ergy to 175.6 MeV, the residual range of which is
16.0 cm after the RS. Although this is deep enough for
most of the cases that need a RS, it still possible that in
some rare cases, such as that of a large tumor extending
proximally to the body surface and distally deep in the
body, higher proton energies may be needed. Measuring
in-air FSFs is still an efficient way to accurately characterize
the in-air proton fluence for energies higher than
175.6 MeV. However, our experience is that direct in-air
proton fluence measurements for higher energies are not
sufficient to configure the PCS algorithm in the Eclipse
TPS. Firstly, with increasing energy there is more and more
of the nuclear interactions that produce the low-dose tails
(halo) in water [9]. The PCS algorithm in Eclipse has some
deficiencies in modelling these halos, and we have to add
some artificial proton fluence in air in order to compensate
for these deficiencies [10]. Secondly, the higher energy pro-
tons have larger ranges in water. Thus, these protons
undergo more scattering and the spot profiles change more
as the beam travels through the water. The optimal fit pa-
rameters obtained from the in-air fluence remain valid only
if the scattering model in the TPS is accurate and the flu-
ence model in air matches the true fluence perfectly. Un-
fortunately neither of these ideal situations is reached in
the current PCS algorithm in the Eclipse TPS. Therefore,
as high energy protons go deep in the water, the optimal fit
parameters found from the in-air measurements may not
be the best fit for the spot profiles in water. It is probably
necessary to measure the spot profiles in water and alter
the in-air fluence model to match the in-water profiles for
higher energies.
In our proton center, we have therefore used in-water
FSFs for the proton energies higher than 175.6 MeV to
configure the proton fluence in the TPS. By adding the
artificial proton fluence, the above-mentioned two defi-
ciencies were mitigated. Since the main purpose of this
paper is to introduce an efficient method with direct in-
air measurements to characterize the proton fluence,
how to configure artificial proton fluence is beyond the
scope of this paper. However, one can refer to a recent
publication by Shen et al. 2016 for the details on config-
uring the artificial fluences [16].
Conclusion
We presented an efficient method for FSF measure-
ments utilizing a spiral spot delivery pattern and inserted
control points. The measured in-air FSFs were used to
fit a double-Gaussian fluence model to characterize the
in-air proton fluence. The optimal fit parameters were
used to configure the PCS algorithm in the Eclipse TPS.
For TPS we have now reached an accuracy of 2% for in-
water single-energy FSFs and for absolute dose of SOBP
fields. We have also achieved a high gamma passing rate
for patient-specific QA.
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